EXPERIMENTAL AND MOLECULAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2023-02-28 momoxiaogu

18天Associate Editor Assigned 希望好运

28 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-12-20 146c5a24m26(暂无昵称) 来自广东省

请问最近有人投这个杂志吗？

46 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2023-02-23 ms8000000651094239 来自广东省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：ljlj

55 0

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-07-21 148893c2m57(暂无昵称)

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：细胞生物;动物实验;分子医学
经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试

47 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-12-30 148893c2m57(暂无昵称)

这个杂志有机会升中科院一区嘛

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-09-14 ms8000000926448182

审稿速度:3.0 | 投稿命中率:50.0
经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有

92 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-10-07 ms1000001831619620

30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-08-08 tomsyu

偏重的研究方向：细胞生物;分子医学
经验分享：Emm有人拒稿过吗？多久拒稿啊？

48 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-03-07 ms1000001879726925

收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？

73 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=2116931, encodeId=3a05211693179, content=18天Associate Editor Assigned 希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Tue Feb 28 18:08:25 CST 2023, time=2023-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106816, encodeId=035d210681669, content=请问最近有人投这个杂志吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Dec 20 15:04:05 CST 2022, time=2022-12-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2116119, encodeId=d58621161191b, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：ljlj, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e685590790, createdName=ms8000000651094239, createdTime=Thu Feb 23 14:19:07 CST 2023, time=2023-02-23, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1233810, encodeId=d04112338107a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：细胞生物;动物实验;分子医学 经验分享：虽然被拒了，但是感觉速度挺快的，投稿后18天得到消息。大家感兴趣的我觉得可以一试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Thu Jul 21 12:34:23 CST 2022, time=2022-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2108215, encodeId=65b62108215a2, content=这个杂志有机会升中科院一区嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e83e5311024, createdName=148893c2m57(暂无昵称), createdTime=Fri Dec 30 22:31:34 CST 2022, time=2022-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248910, encodeId=61a5124891084, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：这个杂志不是一般的慢，8月1号投稿，8月15号时候收到Associate Editor Assigned的主题邮件，到现在都没消息，都不知道送审没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0876145252, createdName=ms8000000926448182, createdTime=Wed Sep 14 17:54:42 CST 2022, time=2022-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092224, encodeId=c1892092224b6, content=30天AE拒了，给了句研究不够深入的评价……感觉这个杂志非常拖沓，浪费一个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0f8267517, createdName=ms1000001831619620, createdTime=Fri Oct 07 09:01:46 CST 2022, time=2022-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237441, encodeId=7539123e441a7, content=偏重的研究方向：细胞生物;分子医学 经验分享：Emm有人拒稿过吗？多久拒稿啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/01/26/7fefbc5f6b3c3f8bead162d3b71ae939.jpg, createdBy=03a685339, createdName=tomsyu, createdTime=Mon Aug 08 22:00:09 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200306, encodeId=6f4c12003065f, content=收到了主题为Associate Editor Assigned的邮件，这说明到哪一阶段了？？送审了没有啊？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6cb35421011, createdName=ms1000001879726925, createdTime=Mon Mar 07 19:21:43 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237392, encodeId=b296123e392e4, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤学 经验分享：审稿速度太慢了。。。 AE assigned 都不知道要多久 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220809/7a610e4d6a994bae9848bbf9dffc2ac7/eeba3728d8e546bcbf8b70dadb2bf4d0.jpg, createdBy=f8985612416, createdName=ms6000000084748419, createdTime=Mon Aug 08 16:37:34 CST 2022, time=2022-08-08, status=1, ipAttribution=)]

2022-08-08 ms6000000084748419

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤学
经验分享：审稿速度太慢了。。。
AE assigned 都不知道要多久

43 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务